NURLF (Neural Therapeutics) Pre-Tax Income: $-0.91 Mil (TTM As of Jan. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Neural Therapeutics Pre-Tax Income?

Neural Therapeutics NURLF Pre-Tax Income is $-0.91 Mil as of Jan. 2026. The stock has 1 warning sign investors should review.

Pretax income is the income that a company earns before paying income taxes. Neural Therapeutics's pretax income for the three months ended in Jan. 2026 was $-0.28 Mil. Its pretax income for the trailing twelve months (TTM) ended in Jan. 2026 was $-0.91 Mil. Neural Therapeutics's pretax margin was %.

Neural Therapeutics  (OTCPK:NURLF) Pre-Tax Income Explanation

Neural Therapeutics's Pretax Margin for the quarter that ended in Jan. 2026 is calculated as

Pretax Margin=Pretax Income/Revenue
=-0.284/0
=%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Neural Therapeutics Pre-Tax Income Related Terms

Neural Therapeutics Pre-Tax Income Historical Data

* Premium members only.

The historical data trend for Neural Therapeutics's Pre-Tax Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Neural Therapeutics Pre-Tax Income Chart

Neural Therapeutics Annual Data
Trend Jul20 Jul21 Jul22 Jul23 Jul24 Jul25
Pre-Tax Income
Get a 7-Day Free Trial -0.31 -1.41 -0.81 -0.49 -0.75

Neural Therapeutics Quarterly Data
Jul20 Jul21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26
Pre-Tax Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.08 -0.70 0.13 -0.05 -0.28

NURLF vs VRTX, REGN, MRNA: Pre-Tax Income Comparison

For the Biotechnology subindustry, Neural Therapeutics's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Neural Therapeutics Pre-Tax Income vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Neural Therapeutics's Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where Neural Therapeutics's Pre-Tax Income falls into.


Neural Therapeutics Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

Neural Therapeutics's Pretax Income for the fiscal year that ended in Jul. 2025 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=-0.734+-0.015+-0.001+0+0.001
=-0.75

Neural Therapeutics's Pretax Income for the quarter that ended in Jan. 2026 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=-0.081+-0.203+0+0+5.5511151231258E-17
=-0.28

Pre-Tax Income for the trailing twelve months (TTM) ended in Jan. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.91 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Pre-Tax Income →
What does a Pre-Tax Income of $-0.91 Mil mean?
Neural Therapeutics (NURLF) has a Pre-Tax Income of $-0.91 Mil as of Jan. 2026. Pre-Tax Income is the total earnings before taxes but after all operating and interest expenses. View historical data on Neural Therapeutics and its competitors.
Is Neural Therapeutics' Pre-Tax Income too high?
Neural Therapeutics' current Pre-Tax Income is $-0.91 Mil.
How does Neural Therapeutics' Pre-Tax Income compare to VRTX and REGN?
Neural Therapeutics' Pre-Tax Income of $-0.91 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Pre-Tax Income for a Biotechnology company?
A good Pre-Tax Income depends on the Biotechnology industry context. However, Pre-Tax Income should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Pre-Tax Income mean?
A high Pre-Tax Income can signal that a stock is expensive relative to its fundamentals. Pre-Tax Income is the total earnings before taxes but after all operating and interest expenses. View historical data on Neural Therapeutics and its competitors. Neural Therapeutics's current Pre-Tax Income is $-0.91 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Neural Therapeutics stock overvalued right now?
Neural Therapeutics (NURLF) has a current Pre-Tax Income of $-0.91 Mil. The current Pre-Tax Income is $-0.91 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Pre-Tax Income calculated?
Pre-Tax Income is calculated from a company's financial statements. For Neural Therapeutics (NURLF), the current Pre-Tax Income is $-0.91 Mil as of Jan. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Neural Therapeutics Business Description

Other Exchanges M6B:GermanyNURL:Canada
Address 1-130 Adelaide Street West, Suite 3002, Toronto, ON, CAN, M5H 3P5
Neural Therapeutics Inc is a wholly-owned subsidiary of High Fusion focused on ethnobotanical drug discovery and development company. Neural Therapeutics is focused on developing products and conducting research on the psychoactive cacti plants with the primary objective to find where the historical use in traditional medicine proves to be effective and capitalizing on the opportunities that can be applied in modern medical and natural health products markets.